WALTHAM, Mass., January 31, 2025--Revvity, Inc. (NYSE: RVTY) today reported financial results for the fourth quarter and full year ended December 29, 2024. WALTHAM ...

Jan 31 (Reuters) - Medical equipment maker Revvity (RVTY.N), opens new tab forecast full-year profit and revenue for 2025 below Wall Street estimates on Friday, as it expects soft demand for its ...

Revvity has acquired companies in sectors with high-growth potential, such as cell and gene therapies, and precision medicine, among other sectors. The company has strengthened its debt position ...

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences in March 2025: 46th Annual Raymond James Institutional Investor ...

Life sciences company Revvity (NYSE:RVTY) in Q4 CY2024, with sales up 4.8% year on year to $729.4 million. On the other hand, the company’s full-year revenue guidance of $2.83 billion at the ...

KeyBanc raised the firm’s price target on Revvity (RVTY) to $145 from $132 and keeps an Overweight rating on the shares. The firm notes that having pre-announced Q4 in mid-January, all eyes were ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Revvity, Inc. (RVTY) on Friday reported fourth-quarter net income of $94.6 million. The Waltham, Massachusetts-based company said it had net income ...

KeyBanc analyst Paul Knight maintained a Buy rating on Revvity (RVTY – Research Report) today and set a price target of $145.00. The company’s shares closed last Friday at $126.13. Leverage ...

Revvity Stock Up 0.2 % Shares of Revvity stock opened at $123.02 on Friday. The stock has a 50-day moving average price of $115.02 and a 200 day moving average price of $117.95. The company has a ...

Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.8% year on year to $729.4 million. On the other hand, the company’s full-year ...